迈克生物：公司暂无已获证的尼帕病毒检测产品

Core Viewpoint - The company currently does not have certified Nipah virus testing products and will evaluate the situation based on clinical urgency, technical feasibility, and compliance with registration procedures [1]. Group 1 - The company responded to investor inquiries regarding the recent outbreak of the Nipah virus, indicating a lack of existing testing products [1][3]. - The company emphasizes a careful decision-making process regarding product development, considering multiple dimensions such as clinical needs and regulatory compliance [1].